Cell Gene Med Company

a biotechnology company developing cell
therapy research and stem cell products

Learn More

Welcome to Cell Gene Med Company

Cell Gene Med is a biotechnology company developing cell therapy research and stem cell products in the field of regenerative medicine to find therapeutic solutions for incurable and debilitating disease.

What We Do

We at Cell Gene , will do our best to produce the innovative cell products with best quality to meet the unmet medical situations. All of our cell based products are manufactured under cGMP compliant facilities and we are proud that we do not use any animal-derived products or antibiotics during the production process.

CLICK THE SYSTEM WHICH YOU HAVE PROBLEM

Our Vision

Our vision is to produce world-class innovative biotech products with regard to the latest standards and respect for our patients value and dignity.

Our Mission

Our mission is to improve the health, quality of life and life expectancy of patients using regenerative medicine.
All of our products, including stem cells, conditioned medium and scaffolds are produced under cGMP compliant facilities with best class xenofree materials.
Retour haut de page

Hi
Here you can see some frequently asked questions or contact us!

What passage are your cells?

Our human mesenchymal stem/stromal cells (hMSCs) are provided at a population doubling level (PDL) of 8-10 post-mononuclear isolation (Bone Marrow; Equivalent Passage 2) or 14-18 post-isolation from the perivascular region of Wharton’s Jelly (Umbilical Cord; Equivalent Passage 3). Due to variabilities of seeding and harvest densities we characterize our MSC “True Age” in terms of their PDL.

How often should I feed your cells?

A: There is no need to feed cells between passages. Our media is engineered to be a batch culture media, where no media exchange or feed is necessary when following our suggested protocols.

Are your vials sold from pooled donors?

No, we do not pool donors at any time during our production. Master Cell Banks (MCBs) are created from each donor source. Working Cell Banks (WCBs) are produced from our MCBs for general product sales.

What characterization do you provide for your hMSCs?

We characterize our hMSCs by following ISCT criteria: cell identity (surface marker expression), functional potency (angiogenic cytokine and IDO secretion), and trilineage differentiation (adipo-, osteo-, and chondrogenesis). This information is provided to allow customers to choose the optimal hMSC tissue type and donor for their specific application or target indication.